(Sharecast News) - Molecular diagnostics group Yourgene Health has expanded its laboratory capabilities to offer Covid-19 testing services and also begun developing its own test kit for the coronavirus.
Yourgene's testing laboratories will support private testing demand as UK GP surgeries, private clinics and other corporate clients struggle to keep up.
The AIM-listed firm said it was also developing its first infectious disease test called Clarigene SARS-CoV-2 test - a molecular Covid-19 assay, which was able to detect whether individuals were currently infected.
Yourgene aims to release a "Research Use Only" version of Clarigene by the end of June 2020.
Chief executive Lyn Rees said: "The addition of the Clarigene infectious disease product portfolio strengthens our offering through our commercial channels and supports one of the strategic pillars of growth - our product diversification strategy."
Yourgene added that its core molecular diagnostics business was performing in line with management's expectations and remained on track to build on its "strong" year-end performance.
As of 0910 BST, Yourgene shares were up 3.51% at 18.89p.
9 Jun 2021 09:58
Yourgene inks agreement with US-based precision medicine company
(Sharecast News) - Molecular diagnostics group Yourgene has inked a licence and supply agreement with an unnamed American precision medicine company.
Read more